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investigated in a cohort of severely immunosuppressed HIV
patients beginning therapy at University Malaya Medical
Centre (UMMC).
Design: Peripheral Blood Mononuclear Cell (PBMC) were
collected at weeks 0, 6, 12, 24 and 48 of ART from ﬁve
patients experiencing IRD (3 with cryptococcal and 2 with
Mycobacterium tuberculosis [Mtb] disease) and eight non-
IRD controls who had begun ART with CD4 T-cell counts of
<100/L.
Methods: T cells producing interferon-gamma (IFN-)
were quantiﬁed by ELISpot assay after stimulation with
puriﬁed protein derivative (PPD), 6 kDa early-secreted
antigenic target (ESAT-6), Cryptococcus neoformans or
Cytomegalovirus (CMV) antigens. Plasma IgG antibody to
these antigens were assayed by ELISA. Proportions of
activated (HLA-DRhi) and regulatory (CD25+CD127lo and
CTLA-4+)-CD4+ T-cells were quantitated by ﬂow cytometry.
Results: IRD patients displayed elevated IFN- responses
and/or plasma IgG antibody to PPD, but none responded
to ESAT-6. Cryptococcal IRD was associated with IFN- and
antibody responses to cryptococcal antigen. Proportions of
activated and natural regulatory CD4+ T-cells (Treg) declined
on ART, but remained higher in patients than healthy con-
trols. At the time of IRD, proportions of activated CD4+
T-cells and Treg were generally elevated relative to other
patients.
Conclusions: Cryptococcal and Mtb IRD generally coin-
cided with peaks in the proportion of activated T-cells,
antigen-speciﬁc IFN- responses and reactive plasma IgG.
IRD did not reﬂect a paucity of Treg.
doi:10.1016/j.ijid.2008.05.611
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The sexual route is the main means of transmission of
the human immunodeﬁciency virus (HIV). With the increas-
ing numbers of HIV-infected women, the investigation of
particular biological features of HIV infection in the genital
tract has become more important. To evaluate HIV genital
shedding during the menstrual cycle, we collected cervico-
vaginal lavages (CVL) from 17 women, assisted at an HIV
outpatient clinic in Sa˜o Paulo, in different hormonal phases
during 2 cycles. HIV-RNA and proviral DNA shedding were
quantiﬁed using RT-PCR and a TaqMan real-time PCR assay,
respectively. In addition, patients were screened for gen-
ital coinfections and had their HIV plasma viral loads and
CD4+ cell counts assessed. Cell-free HIV-RNA and proviral
DNA shedding were found in 18.8% and 31.3% of women.
All patients who shed HIV-RNA were also shown to present
detectable proviral DNA in their CVL, including one woman
with undetectable HIV plasma viral load. No signiﬁcant dif-
ference in viral shedding was seen among menstrual cycle
phases. Six patients from the cohort, who exhibited genital
coinfections previous to admission to the study, had their HIV
genital shedding compared at time of coinfection and after
its resolution. In two of them proviral DNA shedding was
higher at the time of coinfection, caused by Streptococcus
sp and Ureaplasma sp. No cell-free HIV-RNA shedding was
detected in coinfected patients. Our results may contribute
to the understanding of HIV sexual infectivity from women
and emphasize the need for adherence to protected sexual
practices in order to avoid viral transmission.
doi:10.1016/j.ijid.2008.05.612
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Background: Few studies have focused on modiﬁcations
in the genital tract of postmenopausal women and their
association with HIV shedding. In this cross-sectional study
HIV-RNA shedding was compared between fertile and post-
menopausal women followed at a specialized centre in Sao
Paulo, Brazil. Correlations between viral shedding and HIV
viral loads and CD4+ lymphocyte counts were also investi-
gated.
Methods: 146 HIV-infected women [73 postmenopausal
(PM)/73 fertile(F)] were enrolled at the University of Sao
Paulo Medical School. Postmenopausal women referred a
mean duration of 8.17 years since menopause. CD4+ cell
counts were assessed by ﬂow cytometry and HIV-RNA quan-
tiﬁed in plasma and in cervicovaginal lavages (CVL) using
Cobas Amplicor HIV-1 Monitor Ultrasensitive Test. LiCl was
introduced into the CVL buffer and measured before and
after sample collection to determine CVL dilution for each
specimen.
Results: The prevalence of HIV-RNA shedding was simi-
lar in both groups (PM: 17.8%, 95% CI 9.8—28.5 vs. F: 22%,
95% CI 13.1—33.1). Likewise, mean intensity of shedding was
shown not to differ between groups (PM: 2.18log/mL, F:
2.25log/mL). Plasma viral loads were detectable in 34.2%
of postmenopausal, as compared to 42.5% of fertile women
(p = 0.395). Three patients (2 PM/1 F) exhibited HIV shed-
ding in the absence of detectable viraemia. HIV plasma viral
loads and cervicovaginal shedding were signiﬁcantly corre-
lated in both groups (PM: r = 0.658, F: r = 0.684, p < 0.01).
CD4+ cell counts were negatively correlated to HIV shedding
(PM: r =−0.250, F: r =−0.248, p < 0.05).
Conclusions: Despite changes that occur in the vaginal
mucosa of menopausal women, HIV shedding does not seem
to be signiﬁcantly inﬂuenced by this state. Plasma viral loads
and CD4+ cell counts are correlated to HIV shedding, but
these factors alone do not fully predict HIV loads in CVL,
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suggesting that other factors, such as local immunity or
coinfections, may play an important role in viral shedding.
doi:10.1016/j.ijid.2008.05.613
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Background: Infection of HIV-1 can result in a variety of
central nervous system syndromes. Neurons are damaged
through several indirect means. Cytotoxic T-lymphocytes
play important role among other immune processes. The
mechanism of CTL dysfunction as associated with HAD has
not been elucidated. Down-regulation of CD127 on CTL has
been implicated in different situations.
Methodology: Women HIV+ individuals with dementia
(score 7.5) were included. Age matched healthy volunteers
taken as normal control (NC, n = 4). Phenotypic analysis of
peripheral blood cells included for CD4, CD8, CD127, CD45RA
and CD45RO markers on the surface. The percent of CTL
expressing intracellular perforin and granzyme B was evalu-
ated by multicolour ﬂowcytometery. IFN  was estimated by
ELISpot assay and plasma IL-7 levels by ELISA. The statistical
analysis done using PRISM software and two-tailed student’s
‘t’-test.
Results: The mean CD4 count in HAD group with 269
cells/L, and viral load 19095 copies/ml, it was 485 cells/L
and 7527 copies/ml respectively in HIV-ND patients. The
frequency of CD4+CD127+ cells was 9.8% in HAD group
as compared to 17.04% in HIV-ND group and 32.18% in
NC subjects. The percent of CD127 expressing CD8+ cells
was 14.34% in HAD as compared to 18.67% in HIV-ND and
16.65% in NC. CD8+ cells expressing intracellular Granzyme
B and Perforin were 59.4 + 20.9 and 34.05 + 19.09 in HAD
patients as compared to HIV-ND patients (47.5 + 19.55 and
26.94 + 16.17). There was an increase in terminally differen-
tiated effector cells in HAD patients as compared to HIV-ND
patients. A signiﬁcant correlation was found between the
dementia score and the frequency of CD8+ cells expressing
Granzyme B.
Conclusions: The ﬁndings indicate an expansion of acti-
vated CD8+ effector cell subpopulation in the chronically
infected HIV patients with prolonged periods of disease, may
be responsible for enhanced killing of neuronal cells leading
to dementia.
doi:10.1016/j.ijid.2008.05.614
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Background: Human immunodeﬁciency virus Gag is a
highly conserved dominant antigen which induces both
humoral and cellular immune responses during natural infec-
tion. It is a good target for use in serodiagnostics or
vaccine development. However, when Gag is overexpressed
in Escherichia coli, it is highly insoluble and forms protein
aggregates called inclusion bodies. This makes puriﬁcation
of the antigen very difﬁcult. The objective of the current
study was to purify HIV-1 subtype C Gag expressed as inclu-
sion bodies from E. coli for possible use in enzyme-linked
immunosorbent assays.
Methods: A codon-optimized gag gene was cloned into an
expression plasmid which contained a hexa-histidine puriﬁ-
cation tag. The plasmid was used to generate a recombinant
E. coli expressing Gag. The expression of the Gag was
analyzed by SDS-PAGE and Western blotting. The Gag was
puriﬁed from the bacteria using the QIA-Express Fast Start
Ni + NTA kit (QIAGEN, Germany) under denaturing conditions
and conﬁrmed by SDS-PAGE and Western blotting. The puri-
ﬁed Gag was used as a capturing antigen in ELISA tests to
determine the presence of Gag antibodies in sera of an HIV-
positive patient or guinea pigs immunized with a vaccine
expressing Gag-Tat-Nef-RT.
Results: High levels of HIV Gag were expressed in the E.
coli bacteria, but mainly as inclusion bodies. The antigen
was successfully puriﬁed from the inclusion bodies follow-
ing solubilization and its antigenicity was demonstrated by
Western blotting. An ELISA test showed the presence of
Gag antibodies in serum of an HIV-seropositive patient. The
absorbance was 12-times above the background. The ELISA
test further showed that Gag antibodies in sera of HIV
DNA/MVA-vaccinated guinea pigs could be detected.
Conclusion: HIV-1 subtype C Gag expressed in E. coli can
be puriﬁed and used in ELISA tests in diagnostics or vaccine
research.
doi:10.1016/j.ijid.2008.05.615
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Nowadays, there are various HIV-1 subtyping techniques,
among them full-length sequencing is the most accurate
technique to characterize HIV viral genomes and that will
reveal the subtype and any recombinant structure of the
genome. Although sequencing remains the most informative
method, it is technically challenging, time consuming and
expensive for use as a screening tool for large-scale surveil-
lance, especially in developing countries. To circumvent this
problem, easier and faster techniques are needed for rou-
tine subtyping. One of the techniques the Heteroduplex
Mobility Assay (HMA) has been introduced by UNAIDS in sev-
eral developing countries as a tool for monitoring subtypes
distribution. HMA has also been used to rapidly characterize
HIV-1 strains as part of the WHO sponsored vaccine evalua-
tion programmed to identify subtypes and to investigate the
heterogeneity of strains in the different parts of the world
including South East Asia (SEA) countries such as Thailand,
etc. In my study, the Heteroduplex Mobility Assay (HMA) was
started to utilize for the ﬁrst time in Myanmar to determine
